Should liver enzymes be checked in a patient taking niacin?

Journal of Family Practice

Volumn 54, Issue 3, 2005, Pages 265-267

  Rizkallah, Gloria S ^a   Mertens, Marsha K ^b   Brown, Marcy L ^c  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

^b Mercy Family Medicine   (United States)

^c Allegheny Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN; SLO NIACIN; SULFONYLUREA; AMINOTRANSFERASE; ANTILIPEMIC AGENT;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; CLINICAL TRIAL; DRUG FORMULATION; DRUG METABOLISM; DRUG RELEASE; DRUG SCREENING; HEPATITIS; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; MALAISE; NAUSEA; STEATOSIS; SUSTAINED DRUG RELEASE; URINE COLOR; VOMITING; BLOOD; CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; DRUG COMBINATION; ENZYMOLOGY; LIVER; LIVER FUNCTION TEST; REVIEW;

ANTILIPEMIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; NIACIN; TRANSAMINASES;

EID: 14844299337     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)